colitis semaglutide Adjunctive GLP1 Receptor Agonists in Patients With Inflammatory Bowel Diseases and Obesity and/or Diabetes: A Target Trial Emulation Semaglutide versus placebo in individuals

While some evidence suggests that intrusive food thoughts may be more common in individuals with obesity, the relationship is complex and bidirectional

This metabolic transition can manifest as fatigue, especially in the first few weeks of treatment

Insurance coverage will be a challenge if not expanded to include other conditions, one physician said, so FDA approval is paramount. This challenge echoes concerns of patients, who also list high costs as the primary obstacle to GLP-1RA treatment, according to The Cure GLP-1RA Report: Insights from Patients on GLP-1RA Medications and the Future of Obesity Treatment, which reports results of a survey of patients who had taken GLP-1RA medications

Dalile B, Van Oudenhove L, Vervliet B, Verbeke K

The acid might come from vomiting or from backed-up or slowed digestion